There was no mortality data for the patients screened, nor were side effects of endoscopy reported. 3. Serum pepsinogen Level of evidence 2 3: Available data to date are low quality. There is insufficient evidence for use outside of the diagnosis of atrophic gastritis, but DR. Mikki has been working hard using an index that could have greater value, and also working on using gastrin and /or antibodies to H. pylori for screening 4.
3. Pepsinógeno sérico Nivel de evidencia 2 3: Los datos hasta hoy son de baja calidad y no hay evidencia suficiente para su uso fuera del diagnóstico de gastritis atrófico, pero el doctor Mikki viene trabajando intensamente, utilizando un índice que tendría mayor valor, o con gastrina y/o anticuerpos de H. pylori 4.